#INTIENTSummit
Bringing together industry leaders and peers to collaborate and resolve the challenges facing Life Sciences.
At Accenture, our clients, partners and employees remain our top priority. Over the past few weeks, we have been closely monitoring the COVID-19 situation. Based on our latest assessment, we made the difficult decision to cancel the INTIENT Virtual Summit on May 11th, 2020.
While we are disappointed, we believe that this is the right decision given the current circumstances. This allows all of us to focus on our families and our current commitments – including supporting our clients, partners and people.
In the coming weeks, we will release more details about the next INTIENT Summit, taking place on November 17th and 18th. In the meantime, you can add the event to your calendar below and you can find out more about INTIENT.
The INTIENT Summit brought together senior leaders of our industry to share insights, drive innovation and discuss the evolution of platform technology. See more.
View TranscriptLearn more about the topics presented at our INTIENT Summit in Boston, November 2019
Life Sciences: Patient Inspired – read our Day 1 presentations from the November 2019 Summit
Highlights from the INTIENT Summit, Boston 2019
SVP, Chief Digital & Information Officer, Celgene
Head of Clinical Trial Solutions, Noona Healthcare
Senior Vice-President – Pharmacovigilance (PV) and Drug Safety for Alexion
VP of R&D Information Technology, Merck
VP of R&D Technology, GSK
Research Fellow, Eli Lilly
Our theme for the INTIENT Summit 2019 in Boston, MA USA was “Life Sciences: Patient Inspired”. To find out more about our sessions, please get in touch at INTIENT@accenture.com.
DOWNLOAD THE AGENDA8:30 a.m. – 9:00 a.m.
OpeningState Room, 60 State St 33rd Floor, Boston, USA
Welcome to our guests and introduction to the INTIENT Platform.
Senior Managing Director, Accenture
Managing Director, Accenture
State Room, 60 State St 33rd Floor, Boston, USA
9:00 a.m. – 9:30 a.m.
Patient Centricity: Elevating our Mindset from Experimental to EssentialState Room, 60 State St 33rd Floor, Boston, USA
The drive toward patient centricity in the pharmaceutical industry must move beyond pilot projects and isolated experiments to fully scalable solutions. He will offer examples of what’s working, both through the implementation of new technology and in the adoption of new strategic areas of focus.
SVP, Chief Digital & Information Officer, Celgene
State Room, 60 State St 33rd Floor, Boston, USA
9:30 a.m. – 10:00 a.m.
Connecting Commercial Patient Services Capabilities to Clinical Trials SuccessState Room, 60 State St 33rd Floor, Boston, USA
Panel session discussing connecting commercial patient services capabilities to clinical trials success
Head of Clinical Trial Solutions, Noona Healthcare
State Room, 60 State St 33rd Floor, Boston, USA
10:30 a.m. – 11:00 a.m.
Using Real World Data in Drug Safety and Beyond to Advance the Patient ExperienceState Room, 60 State St 33rd Floor, Boston, USA
Exploration of intent and value of harnessing ‘every day’ data for evidence generation in drug safety and across R&D as a Source of Value to Advance the Patient Experience.
Senior Vice-President – Pharmacovigilance (PV) and Drug Safety for Alexion
State Room, 60 State St 33rd Floor, Boston, USA
11:00 a.m. – 11:45 a.m.
Panel Discussion: Patient Centricity in the Digital AgeState Room, 60 State St 33rd Floor, Boston, USA
Panel session with our guests from the morning’s presentations.
Senior Managing Director, Life Sciences, Accenture
SVP, Chief Digital & Information Officer, Celgene
Head of Clinical Trial Solutions, Noona Healthcare
Senior Vice-President – Pharmacovigilance (PV) and Drug Safety for Alexion
Managing Director, Accenture
State Room, 60 State St 33rd Floor, Boston, USA
11:45 a.m. – 12:45 p.m.
Technology Vision for 2020 and Beyond Strategic Partner AnnouncementState Room, 60 State St 33rd Floor, Boston, USA
Solving Big Problems – Together
Chief Strategy Officer
Senior Managing Director, Accenture
State Room, 60 State St 33rd Floor, Boston, USA
1:45 p.m. – 2:15 p.m.
The Impact of an End-to-End Platform Strategy on R&DState Room, 60 State 33rd Floor, Boston, USA
Panel session discussing the impact of an end-to-end platform strategy on R&D.
VP of R&D Information Technology, Merck
State Room, 60 State 33rd Floor, Boston, USA
2:15 p.m. – 2:45 p.m.
Powering a Digital Ecosystem for Clinical DevelopmentState Room, 60 State St 33rd Floor, Boston, USA
Panel session discussing powering a digital ecosystem for clinical development.
VP of R&D Technology, GSK
State Room, 60 State St 33rd Floor, Boston, USA
2:45 p.m. – 3:15 p.m.
Lilly Life Sciences Studio: Transforming Pharmaceutical ResearchState Room, 60 State St 33rd Floor, Boston, USA
Panel session discussing transforming pharmaceutical research.
Research Fellow, Eli Lilly
State Room, 60 State St 33rd Floor, Boston, USA
3:45 p.m. – 4:15 p.m.
Digital Enablement of Enterprise Regulatory ActivitiesState Room, 60 State St 33rd Floor, Boston, USA
Panel session discussing digital enablement of enterprise regulatory activities.
Executive Director, Global Regulatory Affairs, Innovation & Information, Merck
State Room, 60 State St 33rd Floor, Boston, USA
4:15 p.m. – 5:15 p.m.
Panel Discussion: Connecting Across the EnterpriseState Room, 60 State St 33rd Floor, Boston, USA
Panel session discussing connecting across the enterprise.
Senior Managing Director, Accenture
VP of R&D Information Technology, Merck
VP of R&D Technology, GSK
Research Fellow, Eli Lilly
Executive Director, Global Regulatory Affairs, Innovation & Information, Merck
Senior Managing Director, Accenture
Life Sciences Lead, Google Cloud
State Room, 60 State St 33rd Floor, Boston, USA
